KAIST scientists develop tool to fight drug resistance in cancer

KAIST scientists develop tool to fight drug resistance in cancer

One of the biggest obstacles in cancer treatment is drug resistance in cancer cells. Conventional efforts have focused on identifying new drug targets to eliminate these resistant cells, but such approaches can often lead to even stronger resistance.

The MEK effect on cancer — a slow and steady approach to drug resistance

Immuneering Corporation’s investigational MEK inhibitor aims to outpace cancer while reducing resistance and side effects.

Letrozole Drug Reviews: Understanding Its Use and Effectiveness

Letrozole is a medication primarily used for the treatment of hormone receptor-positive breast cancer in postmenopausal women. As a non-steroidal aromatase inhibitor, it works by decreasing the amount of estrogen produced in the body, which can help slow or reverse the growth of certain types of breast tumors that require estrogen to grow. Letrozole is often prescribed for patients who have already undergone surgery or radiation therapy and is w…